Literature DB >> 16785504

Differential effects of IL-15 and IL-21 in myeloid (CD11b+) and lymphoid (CD11b-) bone marrow cells.

Martin Pelletier1, Denis Girard.   

Abstract

IL-15 has been found to activate NF-kappaB in various types of cells. However, the role of this transcription factor in IL-15- and IL-21-stimulated murine bone marrow (BM) cells is unclear. In this study, we demonstrated that both IL-15 and IL-21 are capable of delaying BM cell factor deprivation-induced apoptosis, but only IL-15 induced their proliferation. Following separation of BM cells into myeloid (CD11b(+)) and lymphoid (CD11b(-)) cell populations, we found that IL-15, but not IL-21, significantly induced proliferation in both cell populations. Both cytokines significantly delayed apoptosis, but only in CD11b(-) BM cells. IL-15Ralpha, CD122 (IL-2/15Rbeta), and common gamma-chains (CD132) were expressed in both populations, whereas IL-21Ralpha was expressed only in CD11b(-) BM cells. In addition, we demonstrated that IL-15-induced BM cell proliferation was significantly inhibited in NF-kappaBp50(-/-) mice when compared with littermate controls. The ability of IL-15 and IL-21 to delay BM cell apoptosis was slightly inhibited in NF-kappaBp50(-/-) mice, whereas the antiapoptotic effect of LPS was markedly reversed. We conclude that IL-15, but not IL-21, induces BM cell proliferation and that both cytokines delay BM cell apoptosis. These biological activities were preferentially observed in CD11b(-) BM cells. Using NF-kappaBp50(-/-) mice, we demonstrated for the first time that NF-kappaB plays a greater role in IL-15-induced cell proliferation than in IL-15- and IL-21-induced suppression of apoptosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16785504     DOI: 10.4049/jimmunol.177.1.100

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Analysis of the role of IL-21 in development of murine B cell progenitors in the bone marrow.

Authors:  Nathalie Simard; Danijela Konforte; Anne H Tran; Jessica Esufali; Warren J Leonard; Christopher J Paige
Journal:  J Immunol       Date:  2011-03-23       Impact factor: 5.422

2.  Direct and immune-mediated cytotoxicity of interleukin-21 contributes to antitumor effects in mantle cell lymphoma.

Authors:  Shruti Bhatt; Julie Matthews; Salma Parvin; Kristopher A Sarosiek; Dekuang Zhao; Xiaoyu Jiang; Elif Isik; Anthony Letai; Izidore S Lossos
Journal:  Blood       Date:  2015-07-20       Impact factor: 22.113

Review 3.  The biological functions of NF-kappaB1 (p50) and its potential as an anti-cancer target.

Authors:  Yonghui Yu; Yu Wan; Chuanshu Huang
Journal:  Curr Cancer Drug Targets       Date:  2009-06       Impact factor: 3.428

4.  CD215+ Myeloid Cells Respond to Interleukin 15 Stimulation and Promote Tumor Progression.

Authors:  Shouheng Lin; Guohua Huang; Yiren Xiao; Wei Sun; Yuchuan Jiang; Qiuhua Deng; Muyun Peng; Xinru Wei; Wei Ye; Baiheng Li; Simiao Lin; Suna Wang; Qiting Wu; Qiubin Liang; Yangqiu Li; Xuchao Zhang; Yilong Wu; Pentao Liu; Duanqing Pei; Fenglei Yu; Zhesheng Wen; Yao Yao; Donghai Wu; Peng Li
Journal:  Front Immunol       Date:  2017-12-04       Impact factor: 7.561

5.  IL-15/IL-15Rα Heterodimeric Complex as Cancer Immunotherapy in Murine Breast Cancer Models.

Authors:  Siqi Guo; Ronald B Smeltz; Anthony Nanajian; Richard Heller
Journal:  Front Immunol       Date:  2021-02-08       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.